Northern Trust’s Quince Therapeutics QNCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $128K | Hold |
77,492
| – | – | ﹤0.01% | 4059 |
|
|
2025
Q1 | $103K | Buy |
77,492
+26,968
| +53% | +$35.9K | ﹤0.01% | 4108 |
|
|
2024
Q4 | $94.5K | Buy |
50,524
+16,501
| +48% | +$30.9K | ﹤0.01% | 4162 |
|
|
2024
Q3 | $26.4K | Hold |
34,023
| – | – | ﹤0.01% | 4307 |
|
|
2024
Q2 | $25.5K | Sell |
34,023
-56
| -0.2% | -$42 | ﹤0.01% | 4306 |
|
|
2024
Q1 | $36.1K | Sell |
34,079
-9,779
| -22% | -$10.4K | ﹤0.01% | 4271 |
|
|
2023
Q4 | $46.1K | Hold |
43,858
| – | – | ﹤0.01% | 4247 |
|
|
2023
Q3 | $49.1K | Hold |
43,858
| – | – | ﹤0.01% | 4175 |
|
|
2023
Q2 | $66K | Buy |
43,858
+3,436
| +9% | +$5.17K | ﹤0.01% | 4146 |
|
|
2023
Q1 | $63.1K | Buy |
40,422
+6,683
| +20% | +$10.4K | ﹤0.01% | 4205 |
|
|
2022
Q4 | $21.5K | Sell |
33,739
-12,000
| -26% | -$7.65K | ﹤0.01% | 4473 |
|
|
2022
Q3 | $61K | Sell |
45,739
-87
| -0.2% | -$116 | ﹤0.01% | 4272 |
|
|
2022
Q2 | $102K | Sell |
45,826
-150,482
| -77% | -$335K | ﹤0.01% | 4161 |
|
|
2022
Q1 | $1.22M | Buy |
196,308
+2,747
| +1% | +$17K | ﹤0.01% | 3340 |
|
|
2021
Q4 | $2.44M | Sell |
193,561
-7,187
| -4% | -$90.7K | ﹤0.01% | 3127 |
|
|
2021
Q3 | $18.4M | Sell |
200,748
-4,366
| -2% | -$400K | ﹤0.01% | 1858 |
|
|
2021
Q2 | $10.9M | Buy |
205,114
+35,579
| +21% | +$1.89M | ﹤0.01% | 2306 |
|
|
2021
Q1 | $6.11M | Sell |
169,535
-9,815
| -5% | -$354K | ﹤0.01% | 2626 |
|
|
2020
Q4 | $4.98M | Sell |
179,350
-1,410
| -0.8% | -$39.2K | ﹤0.01% | 2687 |
|
|
2020
Q3 | $9.04M | Buy |
180,760
+5,732
| +3% | +$287K | ﹤0.01% | 2167 |
|
|
2020
Q2 | $8.1M | Buy |
175,028
+47,941
| +38% | +$2.22M | ﹤0.01% | 2229 |
|
|
2020
Q1 | $5.8M | Buy |
127,087
+3,557
| +3% | +$162K | ﹤0.01% | 2207 |
|
|
2019
Q4 | $6.94M | Buy |
123,530
+77,172
| +166% | +$4.33M | ﹤0.01% | 2397 |
|
|
2019
Q3 | $1.16M | Buy |
46,358
+23,035
| +99% | +$575K | ﹤0.01% | 3344 |
|
|
2019
Q2 | $991K | Buy |
+23,323
| New | +$991K | ﹤0.01% | 3361 |
|